Offerings // Monopar Therapeutics

MNPR offering history

Every offering-related filing in Monopar Therapeutics’s recent SEC record — registrations (announced capacity) kept separate from pricing documents (executed sales). Reviewed 536 filings back to Jun 18, 2015.

Last executed offering

Sep 24, 2025

424B5 — priced deal (shares or notes)

Last registration (announced)

Aug 29, 2025

S-3 — capacity, not a sale

Executed, last 12 months

424B pricings + 8-K 3.02 sales

Registered, last 12 months

S-1/S-3/F-series registrations

Date	Filing		What it means
Sep 24, 2025	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Sep 9, 2025	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Aug 29, 2025	S-3 →	REGISTERED	S-3 registration — capacity to sell shares, not a sale yet
Jan 27, 2025	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Jan 27, 2025	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Jan 15, 2025	S-3 →	REGISTERED	S-3 registration — capacity to sell shares, not a sale yet
Dec 23, 2024	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Dec 23, 2024	8-K →	EXECUTED	Unregistered share sale disclosed (8-K item 3.02)
Dec 18, 2024	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Dec 17, 2024	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Nov 29, 2024	S-3 →	REGISTERED	S-3 registration — capacity to sell shares, not a sale yet
Oct 29, 2024	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Oct 28, 2024	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Oct 24, 2024	8-K →	EXECUTED	Unregistered share sale disclosed (8-K item 3.02)
Jan 4, 2023	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Jan 4, 2023	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Dec 21, 2022	S-3 →	REGISTERED	S-3 registration — capacity to sell shares, not a sale yet
Apr 20, 2022	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Jan 13, 2020	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Jan 13, 2020	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Jan 3, 2020	S-3 →	REGISTERED	S-3 registration — capacity to sell shares, not a sale yet
Dec 19, 2019	424B4 →	EXECUTED	Final prospectus — offering priced (typical for IPOs and marketed share deals)
Dec 18, 2019	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Dec 13, 2019	S-1/A →	REGISTERED	S-1/A registration — capacity to sell shares, not a sale yet
Nov 4, 2019	S-1/A →	REGISTERED	S-1/A registration — capacity to sell shares, not a sale yet
Nov 4, 2019	S-1/A →	REGISTERED	S-1/A registration — capacity to sell shares, not a sale yet
Oct 1, 2019	S-1/A →	REGISTERED	S-1/A registration — capacity to sell shares, not a sale yet
Sep 23, 2019	FWP →	MARKETING	Free-writing prospectus — offering being marketed
Sep 13, 2019	S-1/A →	REGISTERED	S-1/A registration — capacity to sell shares, not a sale yet
Sep 10, 2019	S-1/A →	REGISTERED	S-1/A registration — capacity to sell shares, not a sale yet
Aug 15, 2019	S-1 →	REGISTERED	S-1 registration — capacity to sell shares, not a sale yet

MNPR offering-related filings from SEC EDGAR, newest first (capped at 40). Each links to the original document.

Two honest limits. (1) A 424B takedown can price shares or notes — EDGAR’s metadata doesn’t say which, so open the document: large investment-grade filers use these mostly for bond deals (no dilution), small-caps mostly for shares. (2) At-the-market (ATM) programs sell shares gradually and individual sales are not separately filed — the visible footprint is the enabling shelf and its 424B5; actual ATM share counts surface later in the 10-Q/10-K share count. Educational information from public filings, not investment advice.

Is a shelf active now? →Do they need money? →Red flags →Full MNPR workspace →

MNPR offering FAQ

When did MNPR last execute an offering?

Per SEC filings, Monopar Therapeutics's most recent priced offering document is a 424B5 filed 2025-09-24. Note a 424B takedown can price shares or notes (debt) — the linked document says which.

When did MNPR last announce or register an offering?

The most recent registration is a S-3 filed 2025-08-29. A registration is capacity to sell shares — not a sale.

Does an offering always mean dilution?

Registered direct offerings and shelf takedowns issue new shares and dilute existing holders. Resale registrations (424B3/B7) let existing holders sell and do not create new shares. Secondary sales by insiders also do not dilute. Each row here is labeled with what it is.

Free to use. No account, no card.